Abstract
Nine cases of serious lung infectious diseases were treated with PC-904 which was used intravenously by one shot or/and drip infusion; 2g each injection, 1 or 2 times a day, during 4 to 14 days long, in total dosage 14 g in 3 cases, 16 g in 1, 28 g in 3, 56g in 2 cases. All but 1 case, 84 years old man, suffered from acute pneumonia by Enterobacter at the severe condition of bladder cancer, were observed effective clinical results, on the points of views, such as subjective and objective findings, chest X-ray findings and bacteriological changes in sputums. No side effects were observed and no abnormalities were affected on liver, kidney and blood organ functions by using PC-904.
During the past 6 months, we could often observe some patients of lung diseases, showed high titers over 32 times of cold hemoagglutination (CHA) and mycoplasma-CF (MP-CF), and their clinical appearances might be probably modified by clinically unclear infection of mycoplasma pneumoniae among 62 in-patients, 27 (43.6%) in CHA, 16 (25.8%) in MP-CF, and among 41 out-patients, 24 (58.5%) in CHA, 14 (34.2%) in MP-CF.
Then these showed the presence of mycoplasma infection, and it will be necessary to give in combination with the sensitive drugs against the incidental infection at the treatment of serious lung diseases.
